RA0264

antibody from Oursmab
Targeting: FZD10 CD350
Provider product page for RA0264
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0264 - Provider product page
Provider
Oursmab
Product name
Tabituximab (Biosimilar Reference Antibody) (FZD10)
Antibody type
Monoclonal
Description
Tabituximab is a humanized IgG1 kappa monoclonal antibody targeting frizzled class receptor 10 (FZD10), a Wnt pathway receptor overexpressed in certain sarcomas and solid tumors. It binds to FZD10 to inhibit Wnt signaling, which drives tumor growth and metastasis, and may also deliver cytotoxic payloads as an antibody-drug conjugate (ADC). It is being developed for the treatment of FZD10-positive cancers, such as synovial sarcoma and colorectal carcinoma.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
FZD10 protein structure - RA0264 shown in red.